Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis.

Masuda T, Motomura M, Utsugisawa K, Nagane Y, Nakata R, Tokuda M, Fukuda T, Yoshimura T, Tsujihata M, Kawakami A.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):935-40. doi: 10.1136/jnnp-2012-302705. Epub 2012 Jul 4.

PMID:
22764264
[PubMed - indexed for MEDLINE]
2.

[Antibodies in myasthenia gravis].

Eymard B.

Rev Neurol (Paris). 2009 Feb;165(2):137-43. doi: 10.1016/j.neurol.2008.11.020. Epub 2009 Jan 21. Review. French.

PMID:
19162288
[PubMed - indexed for MEDLINE]
3.

Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.

Morell SW, Trinh VB, Gudipati E, Friend A, Page NA, Agius MA, Richman DP, Fairclough RH.

Mol Immunol. 2014 Mar;58(1):116-31. doi: 10.1016/j.molimm.2013.11.005. Epub 2013 Dec 11. Erratum in: Mol Immunol. 2014 May;59(1):117.

PMID:
24333757
[PubMed - indexed for MEDLINE]
4.

The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Tzartos SJ, Cung MT, Demange P, Loutrari H, Mamalaki A, Marraud M, Papadouli I, Sakarellos C, Tsikaris V.

Mol Neurobiol. 1991 Spring;5(1):1-29. Review.

PMID:
1725702
[PubMed - indexed for MEDLINE]
5.

The main immunogenic region of the acetylcholine receptor. Structure and role in myasthenia gravis.

Tzartos SJ, Barkas T, Cung MT, Kordossi A, Loutrari H, Marraud M, Papadouli I, Sakarellos C, Sophianos D, Tsikaris V.

Autoimmunity. 1991;8(4):259-70. Review.

PMID:
1718457
[PubMed - indexed for MEDLINE]
6.

Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.

Aurangzeb S, Tariq M, Irshad M, Badshah M, Khan RS.

J Pak Med Assoc. 2009 May;59(5):289-92.

PMID:
19438131
[PubMed - indexed for MEDLINE]
7.
8.

Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.

Araga S, Galin FS, Kishimoto M, Adachi A, Blalock JB.

J Immunol. 1996 Jul 1;157(1):386-92.

PMID:
8683141
[PubMed - indexed for MEDLINE]
9.

Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.

Barchan D, Asher O, Tzartos SJ, Fuchs S, Souroujon MC.

Eur J Immunol. 1998 Feb;28(2):616-24.

PMID:
9521072
[PubMed - indexed for MEDLINE]
10.

Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.

Lennon VA, Griesmann GE.

Neurology. 1989 Aug;39(8):1069-76.

PMID:
2474772
[PubMed - indexed for MEDLINE]
11.

High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor.

Tsantili P, Tzartos SJ, Mamalaki A.

J Neuroimmunol. 1999 Feb 1;94(1-2):15-27.

PMID:
10376932
[PubMed - indexed for MEDLINE]
12.
13.

Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor.

Wahlsten JL, Lindstrom JM, Ostlie N, Wu XD, Conti-Tronconi BM.

J Recept Res. 1993;13(5):863-79.

PMID:
8463998
[PubMed - indexed for MEDLINE]
14.

Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.

Jacob S, Viegas S, Leite MI, Webster R, Cossins J, Kennett R, Hilton-Jones D, Morgan BP, Vincent A.

Arch Neurol. 2012 Aug;69(8):994-1001. doi: 10.1001/archneurol.2012.437.

PMID:
22689047
[PubMed - indexed for MEDLINE]
15.

Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.

Araga S, LeBoeuf RD, Blalock JE.

Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8747-51. Erratum in: Proc Natl Acad Sci U S A 1994 Feb 15;91(4):1598.

PMID:
8378359
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A.

Brain. 2006 Jun;129(Pt 6):1481-92. Epub 2006 May 3.

PMID:
16672291
[PubMed - indexed for MEDLINE]
Free Article
17.

Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.

Tzartos SJ.

In Vivo. 1988 Jan-Feb;2(1):105-10. Review.

PMID:
2979808
[PubMed - indexed for MEDLINE]
18.

Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?

Sanders DB, Burns TM, Cutter GR, Massey JM, Juel VC, Hobson-Webb L; Muscle Study Group.

Muscle Nerve. 2014 Apr;49(4):483-6. doi: 10.1002/mus.23944.

PMID:
23835683
[PubMed - indexed for MEDLINE]
19.
20.

Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis.

Howard FM Jr, Lennon VA, Finley J, Matsumoto J, Elveback LR.

Ann N Y Acad Sci. 1987;505:526-38.

PMID:
3479935
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk